Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jose Luis Martin is active.

Publication


Featured researches published by Jose Luis Martin.


Investigative Radiology | 1994

Contrast media algogenic potential in peripheral arteriography. Potentiation of bradykinin-induced pain in the rat.

Luis F. Alguacil; Carmen Gonzalez; Florian Böhle; Isabel Jimenez; Cecilio Álamo; Jose Luis Martin

RATIONALE AND OBJECTIVES.Contrast media (CM) with minimal algogenic (pain causing) potential in animal models of peripheral arteriography are still able to produce vascular pain in humans; the poor predictive value of preclinical evaluation led us to develop a more sensitive method based on CM potentiation of bradykinin effects in the rat. METHODS.Behavioral pain responses and histologic alterations of the arteries were determined after intrafemoral injection of bradykinin to saline- or CM-pretreated rats. Pain reactions were compared with those elicited by single and repeated CM injections. RESULTS.Contrast media enhanced bradykinin-induced pain was dose dependent with the following potency order: iopamidol > iopromide > ZK 139129 > ZK 119095. Vasodilation and alterations of the arterial internal layer also swere seen. Iopromide produced this sensitization at doses that did not elicit evident pain reactions per se. CONCLUSION.The method proved to be a highly sensitive preclinical discriminant of CM algogenic potential.


Journal of Chromatography A | 1990

Determination of partition coefficients of non-ionic contrast agents by reversed-phase high-performance liquid chromatography

Ignacio J. Alonso-Silva; Jose Carretero; Jose Luis Martin; Antonio M. Sanz

Abstract Reversed-phase high-performance liquid chromatography was used to measure the lipophilicities of non-ionic contrast agents. Calculated partition coefficients were correlated with the capacity factors extrapolated to zero organic modifier content.


Archive | 1975

2-(4-Isobutyl phenyl)butyric acid, salts thereof, and pharmaceutical compositions containing the same

Luis Aparicio; Nenesio Gayo; Jose Carretero; Jose Luis Martin; Armando Ron


Academic Radiology | 1998

Delayed hypersensitivity to X-ray CM: Possible mechanisms and models

Ulrich Speck; Florian Böhle; Werner Krause; Jose Luis Martin; Heribert Miklautz; Gabriele Schuhmann-Giampieri


Archive | 2003

Trimeric macrocyclically substituted benzene derivatives

Johannes Platzek; Hanns-Joachim Weinmann; Heiko Schirmer; Jose Luis Martin; Juan R. Harto; Bjoern Riefke


Academic Radiology | 2002

ICJ 3393: a new lodinated nonionic low osmolal dimer with low viscosity as contrast agent for X-ray.

B. Riefke; L. González; J. Carretero; C. González; I. Jimenéz; L.F. Alguacil; Florian Böhle; F. Martin; Jose Luis Martin


Archive | 2004

Trimeric macrocyclic substituted benzene derivatives

Heiko Schirmer; Hanns-Joachim Weinmann; Johannes Platzek; Jose Luis Martin; Juan R. Harto; Bjoern Riefke


Archive | 2004

Process for the production of triiodotrimesic acid

Heiko Schirmer; Ulrich Niedballa; Hannelore Niedballa; Johannes Platzek; Jose Luis Martin; Juan R. Harto; Jose Carretero


Investigative Radiology | 1994

NEW IODINATED CONTRAST AGENTS : THE PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES OF ASYMMETRIC DIMERS

Florian Böhle; Jose Carretero; Leonor González; Jose Luis Martin


Archive | 2005

TRIMERIC MACROCYCLIC SUBSTITUTED AMINOISOPHTHALATE HALOPHENYL DERIVATIVES

Juan R. Harto; Jose Luis Martin; Johannes Platzek; Heiko Schirmer; Hanns-Joachim Weinmann; Jose Carretero

Collaboration


Dive into the Jose Luis Martin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Heiko Schirmer

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors

Avatar

Hanns-Joachim Weinmann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hanns-Joachim Weinmann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge